MARINUS PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Three
MARINUS PHARMACEUTICALS, INC. had Long-Term Debt, Maturity, Year Three of $48.75 million as of 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2024-03-05
- 2023-12-31: Long-Term Debt, Maturity, Year Three $48.75M.
- 2023-09-30: Long-Term Debt, Maturity, Year Three $48.75M.
- 2023-06-30: Long-Term Debt, Maturity, Year Three $48.75M.
- 2023-03-31: Long-Term Debt, Maturity, Year Three $48.75M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2023-12-31 | $48.75M 10-K · filed 2024-03-05 |
| 2023-09-30 | $48.75M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $48.75M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $48.75M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.00M 10-K · filed 2023-03-09 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.83M 10-K · filed 2022-03-24 |
| 2021-09-30 | $6.83M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.25M 10-Q · filed 2021-08-10 |
| 2015-12-31 | $1.75M 10-K · filed 2016-03-07 |
| 2014-12-31 | $3.50M 10-K · filed 2015-03-12 |